Impact on U251 Cell Xenograft in vivo through Short Hairpin RNA Targeting Survivin Gene
Hai-ning Zhen,Xiang Zhang,Chang-hong Shi,Tong-tao Yang,Luo-an Fu,Wei Zhang,Xi-ling Wang,Da-kuan Gao,Shi-jie Hu,Lei Song
2005-01-01
Abstract:] BACKGROUND & OBJECTIVE: Survivin gene belongs to family of inhibitor of apoptosisprotein (IAP), having multiple biologic activities including antiapoptosis, promoting cell proliferation and angiogene-sis, however, its role in tumorigenesis andprogression of brain glioma is not completelyclear. The current study was designed to ob-serve the impact of stable transfection of spe-cific short hairpin RNA (shRNA) eukaryoticexpression vector targeting survivin gene ontumorigenesis and angiogenesis of human brain glioblastoma U251 cells in nude mice in vivo. METHODS: U251cells, U251- SR cells transfected stably with shRNA eukaryotic expression vector pWH1- SR targeting survivin gene,and U251- P cells transfected stably with blank pWH1 vector, were inoculated respectively into subcutaneous tissuein flank of nude mice to establish xenograft models of human brain glioma. The tumor growth status was observedand tumor volume was measured termly, and the tumor growth curve was drawn. The animals were killed and thetumor weight was investigated 45 days after inoculation. Protein expression of survivin, proliferating cell nuclearantigen (PCNA) and factor Ⅷ related antigen (FⅧRAg) was investigated by immunohistochemistry SABC method,apoptotic cells were screened by TUNEL method, furthermore proliferative index (PI), apoptotic index (AI) and mi-crovessel density (MVD) were measured respectively in each group of tumor specimens. RESULTS: Comparing withthose in U251 and U251- P groups, in U251- SR group, the tumorigenesis time delayed, tumor grew slow, both tu-mor volume and tumor weight decreased significantly (P<0.01 for both), survivin protein expression was downregu-lated markedly, PI and MVD decreased significantly, whereas AI increased remarkably (P<0.01 for all). CONCLU-SION: The specific shRNA targeting survivin gene can inhibit significantly tumorigenesis and angiogenesis of U251cells in vivo. For this, survivin gene may act as a valuable target for gene therapy of glioma, meanwhile, RNA inter-ference (RNAi) technology may provide a novel and important means for gene therapy of glioma.